Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06843720 · ClinicalTrials.gov registry record · NA
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
A NA study of HR-HPV Testing, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 7,100
- Enrollment target
- 1
- Study location
NCT06843720: Recruiting NA study of HR-HPV Testing, sponsored by M.D. Anderson Cancer Center.
NCT06843720 is a NA study of HR-HPV Testing that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 7,100 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (406% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06843720, a NA study of HR-HPV Testing, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 7,100 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn about the attitudes toward implementing self-collection among healthcare providers and staff, participants, and other stakeholders; and to inform the development of patient education and provider training materials to aid in the implementation of self-collection in clinical settings.
Conditions Studied
Interventions
- BEHAVIORAL HR-HPV Testing
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,100 participants |
| Start Date | 2025-02-17 |
| Est. Completion | 2031-03-31 |
| Phase | NA |
What NCT06843720 shows while recruiting
NCT06843720 is an interventional study that assigns participants to a tested intervention. Its 7,100 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (406% higher).
The record links to 1 condition, with HR-HPV Testing appearing as the primary indexed condition, and to 1 intervention - of which HR-HPV Testing is the first listed.
NCT06843720 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06843720 about?
NCT06843720 is a clinical study titled "Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems". To learn about the attitudes toward implementing self-collection among healthcare providers and staff, participants, and other stakeholders; and to inform the development of patient education and provider training materials to aid in the implementation of self-collection in clinical settings.
What is the current status of trial NCT06843720?
This trial is currently recruiting. It is a NA study. The enrollment target is 7,100 participants. The study started on 2025-02-17. Estimated completion is 2031-03-31.
What conditions does trial NCT06843720 study?
This clinical trial studies the following conditions: HR-HPV Testing.
What interventions are being tested in trial NCT06843720?
The interventions under investigation include: HR-HPV Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT06843720?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06843720 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06843720's enrollment target sits among peer trials
7,100 21st of 2000 higher than 1,980 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05049837 · 7,200 participants
PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification
- NCT06714929 · 7,200 participants · NA
Advancing Water Security: A Community Participatory School-Based Hydration Intervention
- NCT00260585 · 7,000 participants
Esophageal Cancer Risk Registry
- NCT04118660 · 7,000 participants
Thoracic Specimen Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI